Also known as: DB289; Pafuramidine maleate
Pafuramidine (DB289) is an orally bioavailable diamidine prodrug used in the treatment of African sleeping sickness (Trypanosoma brucei gambiense) and Pneumocystis pneumonia. Mediocon Inc manufactures this API at its GMP-certified facility in Aurangabad, Maharashtra, India, ensuring high purity and compliance with international pharmacopoeial standards.
| Parameter | Specification |
|---|---|
| CAS Number | 58-38-0 |
| Molecular Formula | C21H27N7O2·2HCl |
| Molecular Weight | 480.40 g/mol |
| Grade | IP / BP / USP |
| Category | Antiprotozoal / Antimicrobial Agent |
| Appearance | Pale yellow to yellow crystalline powder |
| Solubility | Freely soluble in water, sparingly soluble in ethanol, practically insoluble in ether |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | PAF/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Pafuramidine — CAS 58-38-0 (CAS 58-38-0) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Pafuramidine — CAS 58-38-0 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance